In men with low initial PSA levels (<3 ng/mL), the risk for prostate cancer increases with increasing baseline PSA levels, according to the findings of the Finnish Randomized Study of Screening for prostate cancer.
The authors also suggested rescreening intervals to reduce screening intensity, overdetection, and unnecessary costs of indolent...
